Regulation of Insulin-Like Growth Factor-I (IGF-I) Delivery by IGF Binding Proteins and Receptors



Delivery of growth factors via the bloodstream for the treatment of various diseases is regulated in part by interactions with cell surface binding elements. Understanding the kinetics of growth factor binding and transport by cells would, therefore, be advantageous. This report quantifies the binding, internalization, and transport of insulin-like growth factor-I (IGF-I) across bovine aortic endothelial cells (BAEC) cultured in vitro. Binding analysis indicated that IGF binding proteins (IGFBPs), primarily localized with the extracellular matrix, were the primary IGF-I binding elements in our system, with twice as many binding sites (8.0 ± 1.9 × 104 per cell) as IGF-I receptors (IGF-IR) (3.9 ± 0.6 × 104 per cell). Internalization of IGF-I by IGF-IR, but not IGFBPs, was detected, however both receptor and IGFBP binding were shown to inhibit rather than enhance the transport of intact IGF-I, albeit in different ways. IGFBPs retained IGF-I in the apical region while IGF-IR binding led to protein degradation. Based on our computational modeling and experimental data, we hypothesize that IGFBPs could function as a reservoir for IGF-I, sequestering it for later release and transport, and that this reservoir function of the IGFBPs could be used to promote controlled localized delivery of IGF-I.


Transcytosis Insulin-like growth factor receptor (IGFIR) Insulin-like growth factor binding proteins Endocytosis Mathematical modeling Bovine aortic endothelial cells  Trafficking  


  1. 1.
    Akers, R. M., T. B. McFadden, W. E. Beal, A. J. Guidry, and H. M. Farrell. Radioimmunoassay for measurement of bovine alpha-lactalbumin in serum, milk and tissue culture media. J. Dairy Res. 53:419–429, 1986.PubMedCrossRefGoogle Scholar
  2. 2.
    Allan, G. J., D. J. Flint, and K. Patel. Insulin-like growth factor axis during embryonic development. Reproduction 122:31–39, 2001.PubMedCrossRefGoogle Scholar
  3. 3.
    Ballard, F. J., P. E. Walton, S. Bastian, F. M. Tomas, J. C. Wallace, and G. L. Francis. Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs. Growth Regul. 3:40–44, 1993.PubMedGoogle Scholar
  4. 4.
    Bar, R. S., M. Boes, D. R. Clemmons, W. H. Busby, A. Sandra, B. L. Dake, and B. A. Booth. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGFbinding proteins in the rat heart. Endocrinology 127:497–499, 1990.PubMedGoogle Scholar
  5. 5.
    Bar, R. S., M. Boes, B. L. Dake, A. Sandra, M. Bayne, M. Cascieri, and B. A. Booth. Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I. Endocrinology 127:3243–3245, 1990.PubMedGoogle Scholar
  6. 6.
    Bar, R. S., D. R. Clemmons, M. Boes, W. H. Busby, B. A. Booth, B. L. Dake, and A. Sandra. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology 127:1078–1086, 1990.PubMedGoogle Scholar
  7. 7.
    Banskota, N. K., J. L. Carpentier, and G. L. King. Processing and release of insulin and insulin-like growth factor I by macro-and microvascular endothelial cells. Endocrinology 119:1904–1913, 1986.PubMedGoogle Scholar
  8. 8.
    Bastian, S. E., P. E. Walton, and D. A. Belford. Paracellular transport of insulin-like growth factor-I (IGF-I) across human umbilical vein endothelial cell monolayers. J. Cell Physiol. 170:290–298, 1997.PubMedCrossRefGoogle Scholar
  9. 9.
    Bastian, S. E., P. E. Walton, and D. A. Belford. Transport of circulating IGF-I and LR3IGF-I from blood to extracellular wound fluid sites in rats. J. Endocrinol. 164:77–86, 2000.PubMedCrossRefGoogle Scholar
  10. 10.
    Bayne, M. L., J. Applebaum, G. G. Chicchi, R. E. Miller, and M. A. Cascieri. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J. Biol. Chem. 265:15648–15652, 1990.PubMedGoogle Scholar
  11. 11.
    Biegel, D., and J. S. Pachter. Growth of brain microvessel endothelial cells on collagen gels: applications to the study of blood-brain barrier physiology and CNS inflammation. In Vitro Cell Dev. Biol. Anim. 30A:581–588, 1994.PubMedCrossRefGoogle Scholar
  12. 12.
    Boes, M., B. L. Dake, B. A. Booth, A. Sandra, M. Bateman, K. L. Knudtson, and R. S. Bar. IGF-I and IGFBP-3 transport in the rat heart. Am. J. Physiol. Endocrinol. Metab. 284:E237–239, 2003.PubMedGoogle Scholar
  13. 13.
    Chow, J. C., G. Condorelli, and R. J. Smith. Insulin-like growth factor-I receptor internalization regulates signaling via the shc/mitogen activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J. Biol. Chem. 273:4672–4680, 1998.PubMedCrossRefGoogle Scholar
  14. 14.
    Delafontaine, P., Y. H. Song, and Y. Li. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 24:435–44, 2004.PubMedCrossRefGoogle Scholar
  15. 15.
    Dunger, D. B., C. L. Acerini. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes? Diabet. Med. 14:723–731, 1997.PubMedCrossRefGoogle Scholar
  16. 16.
    Dunker, N., and K. Krieglstein. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267:6982–6988, 2000.PubMedCrossRefGoogle Scholar
  17. 17.
    Elhadj, S., R. M. Akers, K. Forsten-Williams. Chronic pulsatile shear stress alters insulin-like growth factor-I (IGF-I) binding protein release in vitro. Ann. Biomed. Eng. 31:163–170, 2003.PubMedCrossRefGoogle Scholar
  18. 18.
    Forbes, B. E., P. J. Hartfield, K. A. McNeil, K. H. Surinya, S. J. Milner, L. J. Cosgrove, and J. C. Wallace. Characteristics of binding of insulinlike growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur. J. Biochem. 269:961–968, 2002.PubMedCrossRefGoogle Scholar
  19. 19.
    Frank, H. J., W. M. Pardridge, W. L. Morris, R. G. Rosenfeld, and T. B. Choi. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes 35:654–661, 1986.PubMedCrossRefGoogle Scholar
  20. 20.
    Franklin, S. L., R. J. Ferry Jr., and P. Cohen. Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. J. Clin. Endocrinol. Metab. 88:900–907, 2003.PubMedCrossRefGoogle Scholar
  21. 21.
    Garcia, A. M., N. Szasz, S. B. Trippel, T. I. Morales, A. J. Grodzinsky, and E. H. Frank. Transport and binding of insulin-like growth factor I through articular cartilage. Arch. Biochem. Biophys. 415:69–79, 2003.PubMedCrossRefGoogle Scholar
  22. 22.
    Gospodarowicz, D., D. Delgado, and I. Vlodavsky. Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc. Natl. Acad. Sci. U.S.A. 77:4094–4098, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Grulich-Henn, J., J. Ritter, S. Mesewinkel, U. Heinrich, M. Bettendorf, and K. T. Preissner. Transport of insulin-like growth factor-I across endothelial cell monolayers and its binding to the subendothelial matrix. Exp. Clin. Endocrinol. Diab. 110:67–73, 2002.CrossRefGoogle Scholar
  24. 24.
    Guevara-Aguirre, J., O. Vasconez, V. Martinez, A. L. Martinez, A. L. Rosenbloom, F. B. Diamond Jr., S. E. Gargosky, L. Nonoshita, and R. G. Rosenfeld. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J. Clin. Endocrinol. Metab. 80:1393–1398, 1995.PubMedCrossRefGoogle Scholar
  25. 25.
    Happerfield, L. C., D. W. Miles, D. M. Barnes, L. L. Thomsen, P. Smith, and A. M. Hanby. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. J. Pathol. 183:412–417, 1997.PubMedCrossRefGoogle Scholar
  26. 26.
    Heding, A., R. Gill, Y. Ogawa, P. De Meyts, and R. M. Shymko. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3. J. Biol. Chem. 271:13948–13952, 1996.PubMedCrossRefGoogle Scholar
  27. 27.
    Hemar, A., M. Lieb, A. Subtil, J. P. DiSanto, and A. Dautry-Varsat. Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain. Eur. J. Immunol. 24:1951–1955, 1994.PubMedCrossRefGoogle Scholar
  28. 28.
    Hossenlopp, P., D. Seurin, B. Segovia-Quinson, S. Hardouin, and M. Binoux. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:138–143, 1986.PubMedCrossRefGoogle Scholar
  29. 29.
    Jansson, M., D. Hallen, H. Koho, G. Andersson, L. Berghard, J. Heidrich, E. Nyberg, M. Uhlen, J. Kordel, and B. Nilsson. Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change. J. Biol. Chem. 272:8189–8197, 1997.PubMedCrossRefGoogle Scholar
  30. 30.
    Kelley, K. M., Y. Oh, S. E. Gargosky, Z. Gucev, T. Matsumoto, V. Hwa, L. Ng, D. M. Simpson, and R. G. Rosenfeld. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28:619–637, 1996.PubMedCrossRefGoogle Scholar
  31. 31.
    Kil, S. J., M. Hobert, and C. Carlin. A leucine-based determinant in the epidermal growth factor receptor juxtamembrane domain is required for Regulation of IGF-I Transport by IGFBPs and IGF-IR 33 the efficient transport of ligand-receptor complexes to lysosomes. J. Biol. Chem. 274:3141–3150, 1999.PubMedCrossRefGoogle Scholar
  32. 32.
    King, G. L., A. D. Goodman, S. Buzney, A. Moses, and C. R. Kahn. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 75:1028–1036, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Kondo, T., D. Vicent, K. Suzuma, M. Yanagisawa, G. L. King, M. Holzenberger, and C. R. Kahn. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J. Clin. Invest. 111:1817–1819, 2003.Google Scholar
  34. 34.
    Laron, Z.. Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts potent. Drugs 45:1–8, 1993.Google Scholar
  35. 35.
    Lauffenburger, D. A., and J. J. Linderman. Receptors. New York: Oxford, 1993, 365p.Google Scholar
  36. 36.
    Lee, K. W., B. Liu, L. Ma, H. Li, P. Bang, H. P. Koeffler, and P. Cohen. Cellular internalization of insulin-like growth factor binding protein-3 (IGFBP-3): Distinct endocytic pathways facilitate reuptake and nuclear localization. J. Biol. Chem. 279:469–476, 2004.PubMedCrossRefGoogle Scholar
  37. 37.
    Liu, B., S. A. Weinzimer, T. B. Gibson, D. Mascarenhas, and P. Cohen. Type Ialpha collagen is an IGFBP-3 binding protein. Growth Horm. IGF Res. 13:89–97, 2003.PubMedCrossRefGoogle Scholar
  38. 38.
    Lund, K., L. Opresko, C. Starbuck, B. Walsh, and H. Wiley. Quantitative analysis of the endocytic system involved in hormone- induced receptor internalization. J. Biol. Chem. 265:15713–15723, 1990.PubMedGoogle Scholar
  39. 39.
    Maratos-Flier, E., C. Y. Kao, E. M. Verdin, and G. L. King. Receptormediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J. Cell Biol. 105:1595–1601, 1987.PubMedCrossRefGoogle Scholar
  40. 40.
    Martin, J. A., B. A. Miller, M. B. Scherb, L. A. Lembke, and J. A. Buckwalter. Colocalization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage. Osteoarthritis Cartilage 10:556–563, 2002.PubMedCrossRefGoogle Scholar
  41. 41.
    Morla, A., Z. Zhang, and E. Ruoslahti. Superfibronectin is a functionally distinct form of fibronectin. Nature 367:193–196, 1994.PubMedCrossRefGoogle Scholar
  42. 42.
    Morrow, L. A., M. B. O’Brien, D. E. Moller, J. S. Flier, and A. C. Moses. Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J. Clin. Endocrinol. Metab. 79:205–210, 1994.PubMedCrossRefGoogle Scholar
  43. 43.
    Nugent, M. A., and E. R. Edelman. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: A mechanism for cooperactivity. Biochemistry 31:8876–8883, 1992.PubMedCrossRefGoogle Scholar
  44. 44.
    Oh, Y., H. L. Muller, G. Lamson, and R. G. Rosenfeld. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J. Biol. Chem. 268:14964–14971, 1993.PubMedGoogle Scholar
  45. 45.
    O’Kane, S., and M. W. Ferguson. Transforming growth factor beta s and wound healing. Int. J. Biochem. Cell Biol. 29:63–78, 1997.PubMedCrossRefGoogle Scholar
  46. 46.
    Payet, L. D., S. M. Firth, and R. C. Baxter. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J. Clin. Endocrinol. Metab. 89:2382–2389, 2004.PubMedCrossRefGoogle Scholar
  47. 47.
    Quattrin, T., K. Thrailkill, L. Baker, J. Litton, K. Dwigun, M. Rearson, M. Poppenheimer, D. Giltinan, N. Gesundheit, and P. Martha, Jr. Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile. Diab. Care 20:374–380, 1997.CrossRefGoogle Scholar
  48. 48.
    Rao, B. M., I. Driver, D. A. Lauffenburger, and K. D. Wittrup. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alphasubunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect. Mol. Pharmacol. 66:864–869, 2004.PubMedGoogle Scholar
  49. 49.
    Rite, S., A. Baldellou, P. Giraldo, J. I. Labarta, M. Giralt, D. Rubio-Felix, A. Guallar, J. I. Perez-Calvo, E. Mayayo, A. Ferrandez, and M. Pocovi. Insulin-like growth factors in childhood-onset Gaucher disease. Pediatr. Res. 52:109–112, 2002.PubMedCrossRefGoogle Scholar
  50. 50.
    Roberson, J. G., D. A. Belford, and F. J. Ballard. Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. Am. J. Physiol. 276:E663–E671, 1999.Google Scholar
  51. 51.
    Rosenzweig, S. A. What's new in the IGF-binding proteins? Growth Horm. IGF Res. 14:329–336, 2004.PubMedCrossRefGoogle Scholar
  52. 52.
    Schalch, D. S., C. M. Sessions, A. C. Farley, A. Masakawa, C. A. Emler, and D. G. Dills. Interaction of insulin-like growth factor I/somatomedin- C with cultured rat chondrocytes: Receptor binding and internalization. Endocrinology 118:1590–1597, 1986.PubMedGoogle Scholar
  53. 53.
    Schedlich, L. J., S. L. Le Page, S. M. Firth, L. J. Briggs, D. A. Jans, and R. C. Baxter. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J. Biol. Chem. 275:23462–23470, 2000.PubMedCrossRefGoogle Scholar
  54. 54.
    Singh, B. K., D. A. Charkowicz, and D. Mascarenhas. IGF-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. J. Biol. Chem. 279:477–487, 2004 PubMedCrossRefGoogle Scholar
  55. 55.
    Spranger, J., J. Buhnen, V. Jansen, M. Krieg, R. Meyer-Schwickerath, W. F. Blum, H. Schatz, and A. F. Pfeiffer. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy. Horm. Metab. Res. 32:196–200, 2000.PubMedGoogle Scholar
  56. 56.
    Vorwerk, P., B. Hohmann, Y. Oh, R. G. Rosenfeld, and R. M. Shymko. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N-and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor. Endocrinology 143:1677–1685, 2002.PubMedCrossRefGoogle Scholar
  57. 57.
    Wong, M. S., C. C. Fong, and M. Yang. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins. Biochim. Biophys. Acta 1432:293–301, 1999.PubMedGoogle Scholar

Copyright information

© Biomedical Engineering Society 2006

Authors and Affiliations

  • Julie M. D. Paye
    • 1
  • Kimberly Forsten-Williams
    • 1
    • 2
  1. 1.Department of Chemical EngineeringVirginia Polytechnic Institute and State UniversityBlacksburgUSA
  2. 2.Department of Chemical EngineeringVirginia Polytechnic Institute and State UniversityBlacksburgUSA

Personalised recommendations